Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5777433

O=C(CCc1cnoc1-c1ccc(F)cc1)N1CCN(c2ccc(F)cc2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.53
KMT2A Q03164 3/20 0.48
LMNA P02545 2/20 0.48
ALDH1A1 P00352 1/20 0.47
HPGD P15428 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MEN1 O00255 1/20 0.45
PARP1 P09874 1/20 0.45
PARP2 Q9UGN5 1/20 0.45
MAPT P10636 8/20 0.44
POLB P06746 4/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
TP53 P04637 1/20 0.44
GAA P10253 1/20 0.44
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5772610 0.96 GFER (0.53) GFERKMT2ALMNAMEN1PARP1
Trifluoroacetic Acid SCHEMBL5774077 0.95 POLB (0.51) GFERKMT2ALMNAALDH1A1HPGD
Trifluoroacetic Acid SCHEMBL5770044 0.94 RXFP1 (0.49) GFERKMT2ALMNAALDH1A1HPGD
Trifluoroacetic Acid SCHEMBL5771192 0.93 MEN1 (0.53) GFERKMT2ALMNAALDH1A1MEN1
Trifluoroacetic Acid SCHEMBL5776129 0.89 MEN1 (0.50) GFERKMT2ALMNAALDH1A1MEN1
Trifluoroacetic Acid SCHEMBL5776834 0.89 HTT (0.46) GFERKMT2ALMNAHPGDMAPT
Trifluoroacetic Acid SCHEMBL5776691 0.89 GRM5 (0.48) GFERALDH1A1MAPTPOLBNPC1
Trifluoroacetic Acid SCHEMBL5772135 0.89 MAPT (0.56) GFERKMT2ALMNAALDH1A1MEN1
Trifluoroacetic Acid SCHEMBL5777378 0.89 MAPT (0.50) GFERKMT2ALMNAHPGDMEN1
Trifluoroacetic Acid SCHEMBL5775321 0.88 KMT2A (0.53) GFERKMT2ALMNAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR GFER 811/4885KMT2A 3907/4885LMNA 2770/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 GFER 1403/4885KMT2A 2906/4885LMNA 2605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.